CMS proposes rule to update Medicare payments and transparency requirements for hospice care

Radiation oncologists hit hard after Medicare cuts, ASTRO survey finds

Two-thirds of radiation oncologists surveyed by the American Society for Radiation Oncology in March are seeing Medicare reimbursements decline by 10% or more, according to a report published on April 1.

PanTracer LBx liquid biopsy profiling test receives Medicare coverage

NeoGenomics announced the PanTracer LBx test has received coverage from CMS’ Molecular Diagnostics Services Program under Local Coverage Determination - MolDX: Plasma-Based Genomic Profiling in Solid Tumors.

March 20, 2026

Vol.52 No.11

Clinical Trials & Tribulations

Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore

In the United States, 18.6 million people are living with cancer, and nearly 40% of Americans will face a cancer diagnosis in their lifetime.

January 30, 2026

Vol.52 No.04

By Les Biller

Cancer Policy

CMS to enter negotiations with drugmakers over the price of four cancer medications

The Center for Medicare and Medicaid Services is entering negotiations with drugmakers over the price of 15 medications this year. The newly announced list includes four drugs used to treat cancer.

With five-year cancer survival at an all-time high, does this mean people are living longer?

“It's really, really important that every year since 1991, cancer mortality has dropped by a little bit, and it did again!” said Paul Goldberg, editor and publisher of The Cancer Letter. “Now, mortality is a good metric, age-adjusted mortality. As far as survival, well, that's not so good.”

January 21, 2026

Clinical Health Equity

New Medicaid work requirements could lead to 1.6 million missed cancer screenings over two years

New Medicaid work requirements included in President Donald Trump’s “One Big Beautiful Bill Act” could result in as many as 1.6 million missed screenings for breast, colon, and lung cancers within the first two years, researchers at the University of Chicago reported in a paper published in JAMA Oncology earlier this month.

January 16, 2026

Vol.52 No.02

By Sara Willa Ernst

CMS proposes rule to update Medicare payments and transparency requirements for hospice care

YOU MAY BE INTERESTED IN

Radiation oncologists hit hard after Medicare cuts, ASTRO survey finds

PanTracer LBx liquid biopsy profiling test receives Medicare coverage

Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore

CMS to enter negotiations with drugmakers over the price of four cancer medications

With five-year cancer survival at an all-time high, does this mean people are living longer?

New Medicaid work requirements could lead to 1.6 million missed cancer screenings over two years

Renew today!

Subscriber content

Never miss an issue!

Login